A reduction in serum TRACP-5b in conjunction with an incremental change of serum PINP elucidated the osteoporotic fatalism in patients with CKD-MBD was reversed by Calcimimetic therapy along with the improvement of CRP as an indicator of bone inflammation. The gene discussed is ACP5; the disease is Marchiafava-Bignami disease.